10440

    500257

    LUPIN

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    LUPIN LIMITED Share Price Today

    LUPIN LIMITED is currently trading at ₹2491.6, up by ₹15.6 from the previous close. The stock touched an intraday high of ₹2504.60 and a low of ₹2474.10 during the latest trading session. Over the past one year, LUPIN LIMITED has delivered a return of 26.66%, while the stock has gained 9.49% in the last one month.

    LUPIN LIMITED performance

    Today’s low Today’s high
    ₹ 2474.10 ₹ 2504.60
    ₹ 2491.60
    52 week low 52 week high
    ₹ 1836.80 ₹ 2504.60
    ₹ 2491.60
    Open Price ₹ 2489.90
    Prev. Close ₹ 2476.00
    Volume (Shares) 430477.00
    Total traded value ₹ 10725.76
    Upper Circuit ₹ 2723.60
    Lower Circuit ₹ 2228.40
    info

    Investment Returns

    Over 1 Month 9.49% Over 3 Months 8.60% Over 6 Months 18.82% Over 1 Year 26.66%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    LUPIN LIMITED fundamentals


    • Market cap (Cr) 1,13,924.10
    • P/E Ratio (TTM) 17.78
    • Beta 0.56
    • Book Value / share 659.04
    • Return on equity 17.70%
    • EPS (TTM) 131.91
    • Dividend yield 0.73%
    • Net profit/quarter (Cr) 2,163.69
    info icon alternate text
    • Market cap (Cr) 1,13,962.90
    • P/E Ratio (TTM) 17.78
    • Beta 0.54
    • Book Value / share 659.04
    • Return on equity 17.70%
    • EPS (TTM) 131.91
    • Dividend yield 0.73%
    • Net profit/quarter (Cr) 2,163.69
    info icon alternate text

    LUPIN LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 5152.26
    Operating Expense 3168.81
    Net Profit 2163.69
    Net Profit Margin (%) 41.99
    Earnings Per Share (EPS) 37.01
    EBITDA 2818.17
    Effective Tax Rate (%) 16.85
    Particulars DEC 2025 (Values in Cr)
    Revenue 4433.96
    Operating Expense 3099.21
    Net Profit 717.45
    Net Profit Margin (%) 16.18
    Earnings Per Share (EPS) 15.71
    EBITDA 1082.64
    Effective Tax Rate (%) 17.33
    Particulars SEP 2025 (Values in Cr)
    Revenue 3852.79
    Operating Expense 3095.15
    Net Profit 1357.35
    Net Profit Margin (%) 35.23
    Earnings Per Share (EPS) 29.72
    EBITDA 1838.31
    Effective Tax Rate (%) 17.02
    Particulars JUN 2025 (Values in Cr)
    Revenue 5605.41
    Operating Expense 3174.58
    Net Profit 2128.07
    Net Profit Margin (%) 37.96
    Earnings Per Share (EPS) 46.60
    EBITDA 2783.78
    Effective Tax Rate (%) 17.77
    Particulars MAR 2025 (Values in Cr)
    Revenue 4382.69
    Operating Expense 2981.37
    Net Profit 1291.35
    Net Profit Margin (%) 29.46
    Earnings Per Share (EPS) 28.30
    EBITDA 1794.91
    Effective Tax Rate (%) 16.85
    Particulars MAR 2026 (Values in Cr)
    Revenue 19044.42
    Operating Expense 12537.75
    Net Profit 6366.56
    Net Profit Margin (%) 33.43
    Earnings Per Share (EPS) 129.18
    EBITDA 8522.90
    Effective Tax Rate (%) 17.25
    Particulars MAR 2025 (Values in Cr)
    Revenue 16458.58
    Operating Expense 12227.21
    Net Profit 3972.96
    Net Profit Margin (%) 24.13
    Earnings Per Share (EPS) 87.10
    EBITDA 5569.30
    Effective Tax Rate (%) 17.86
    Particulars MAR 2024 (Values in Cr)
    Revenue 14316.43
    Operating Expense 11988.54
    Net Profit 2326.09
    Net Profit Margin (%) 16.24
    Earnings Per Share (EPS) 51.10
    EBITDA 3565.79
    Effective Tax Rate (%) 16.46
    Particulars MAR 2023 (Values in Cr)
    Revenue 11043.07
    Operating Expense 10822.95
    Net Profit 425.21
    Net Profit Margin (%) 3.85
    Earnings Per Share (EPS) 9.35
    EBITDA 1173.92
    Effective Tax Rate (%) 19.33
    Particulars MAR 2022 (Values in Cr)
    Revenue 11258.48
    Operating Expense 12083.61
    Net Profit -188.70
    Net Profit Margin (%) -1.67
    Earnings Per Share (EPS) -4.16
    EBITDA 426.13
    Effective Tax Rate (%) -16.82
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 376.77
    ROE % 21.00
    ROCE % 20.88
    Total Debt to Total Equity 0.27
    EBITDA Margin 24.13
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 313.59
    ROE % 14.47
    ROCE % 15.34
    Total Debt to Total Equity 0.28
    EBITDA Margin 19.64
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 273.95
    ROE % 3.64
    ROCE % 5.70
    Total Debt to Total Equity 0.35
    EBITDA Margin 11.25
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 267.40
    ROE % -11.63
    ROCE % -6.70
    Total Debt to Total Equity 0.34
    EBITDA Margin 2.62
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 304.23
    ROE % 9.32
    ROCE % 9.16
    Total Debt to Total Equity 0.42
    EBITDA Margin 17.84
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 531.72
    ROE % 17.70
    ROCE % 21.32
    Total Debt to Total Equity 0.01
    EBITDA Margin 32.82
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 452.12
    ROE % 11.92
    ROCE % 13.96
    Total Debt to Total Equity 0.02
    EBITDA Margin 24.31
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 404.66
    ROE % 2.33
    ROCE % 3.21
    Total Debt to Total Equity 0.05
    EBITDA Margin 10.43
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 399.34
    ROE % -1.19
    ROCE % -0.61
    Total Debt to Total Equity 0.04
    EBITDA Margin 3.36
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 409.20
    ROE % 6.98
    ROCE % 8.95
    Total Debt to Total Equity 0.01
    EBITDA Margin 19.66
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3142.33
    Total Assets 29204.88
    Total Liabilities 29204.88
    Total Equity 17294.35
    Share Outstanding 45
    Price to Book Ratio 3.81
    Return on Assets (%) 11.23
    Return on Capital (%) 14.67
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1202.54
    Total Assets 23997.18
    Total Liabilities 23997.18
    Total Equity 14373.45
    Share Outstanding 45
    Price to Book Ratio 3.58
    Return on Assets (%) 7.97
    Return on Capital (%) 11.23
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1293.13
    Total Assets 22955.93
    Total Liabilities 22955.93
    Total Equity 12542.82
    Share Outstanding 45
    Price to Book Ratio 1.60
    Return on Assets (%) 1.87
    Return on Capital (%) 2.56
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1098.13
    Total Assets 21821.22
    Total Liabilities 21821.22
    Total Equity 12221.98
    Share Outstanding 45
    Price to Book Ratio 1.87
    Return on Assets (%) -7.00
    Return on Capital (%) -9.51
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1742.46
    Total Assets 23610.44
    Total Liabilities 23610.44
    Total Equity 13858.11
    Share Outstanding 45
    Price to Book Ratio 2.49
    Return on Assets (%) 5.15
    Return on Capital (%) 6.53
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 458.58
    Total Assets 28431.99
    Total Liabilities 28431.99
    Total Equity 24278.24
    Share Outstanding 45
    Price to Book Ratio 3.81
    Return on Assets (%) 13.97
    Return on Capital (%) 16.36
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 138.64
    Total Assets 24922.86
    Total Liabilities 24922.86
    Total Equity 20603.09
    Share Outstanding 45
    Price to Book Ratio 3.58
    Return on Assets (%) 9.33
    Return on Capital (%) 11.28
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 100.97
    Total Assets 22683.67
    Total Liabilities 22683.67
    Total Equity 18411.86
    Share Outstanding 45
    Price to Book Ratio 1.60
    Return on Assets (%) 1.87
    Return on Capital (%) 2.23
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 64.56
    Total Assets 22313.37
    Total Liabilities 22313.37
    Total Equity 18150.19
    Share Outstanding 45
    Price to Book Ratio 1.87
    Return on Assets (%) -0.84
    Return on Capital (%) -1
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 284.01
    Total Assets 21858.56
    Total Liabilities 21858.56
    Total Equity 18565.57
    Share Outstanding 45
    Price to Book Ratio 2.49
    Return on Assets (%) 5.75
    Return on Capital (%) 6.67
    Particulars MAR 2025 (Values in Cr)
    Net Income 4015.00
    Cash from Operations 3905.98
    Cash from Investing -4171.89
    Cash from Financing 1731.88
    Net change in Cash 559.93
    Free Cash Flow 5588.41
    Particulars MAR 2024 (Values in Cr)
    Net Income 2422.27
    Cash from Operations 3974.41
    Cash from Investing -1712.20
    Cash from Financing -2184.21
    Net change in Cash -248.05
    Free Cash Flow 4903.30
    Particulars MAR 2023 (Values in Cr)
    Net Income 716.49
    Cash from Operations 2140.42
    Cash from Investing -1286.77
    Cash from Financing -337.25
    Net change in Cash 273.22
    Free Cash Flow 3640.04
    Particulars MAR 2022 (Values in Cr)
    Net Income -1372.21
    Cash from Operations 320.43
    Cash from Investing 1292.23
    Cash from Financing -1572.32
    Net change in Cash 87.22
    Free Cash Flow 1225.51
    Particulars MAR 2021 (Values in Cr)
    Net Income 1676.45
    Cash from Operations 2537.27
    Cash from Investing -1239.58
    Cash from Financing -1885.27
    Net change in Cash -1303.09
    Free Cash Flow 3214.89
    Particulars MAR 2025 (Values in Cr)
    Net Income 4837.12
    Cash from Operations 3252.84
    Cash from Investing -1766.32
    Cash from Financing -460.23
    Net change in Cash 218.10
    Free Cash Flow 4547.22
    Particulars MAR 2024 (Values in Cr)
    Net Income 2784.69
    Cash from Operations 2650.78
    Cash from Investing -1599.02
    Cash from Financing -867.07
    Net change in Cash 38.04
    Free Cash Flow 3349.32
    Particulars MAR 2023 (Values in Cr)
    Net Income 527.14
    Cash from Operations 1920.79
    Cash from Investing -1269.17
    Cash from Financing -498.26
    Net change in Cash 26.56
    Free Cash Flow 2495.92
    Particulars MAR 2022 (Values in Cr)
    Net Income -161.53
    Cash from Operations 2.86
    Cash from Investing -371.79
    Cash from Financing 102.45
    Net change in Cash -118.31
    Free Cash Flow 600.06
    Particulars MAR 2021 (Values in Cr)
    Net Income 1629.70
    Cash from Operations 1998.72
    Cash from Investing -2507.52
    Cash from Financing -53.17
    Net change in Cash -990.61
    Free Cash Flow 2518.55
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 13.52 1.58 250.74 23.12 38.85
    BLISS GVS PHARMA LTD 506.15 40.69 4.49 5368.04 118.35 552.90
    CIPLA LTD 1458.45 30.95 3.42 117820.20 1165.55 1672.20
    FERMENTA BIOTECH LTD. 345.85 15.26 2.50 1017.87 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 22.88 4.21 250.74 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.85 24.06 4.19 1552.07 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8297.90 108.37 23.76 20744.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 506.15 54.72 4.64 5368.04 118.35 552.90

    LUPIN LIMITED shareholding pattern

    Holding
    6.11%
    46.85%
    21.7%
    25.32%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    LUPIN LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    2491.60 0.63 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 2419.60
    • 26 Days 2341.30
    • 10 Days 2389.10
    • 50 Days 2317.60
    • 12 Days 2379.50
    • 100 Days 2278.00
    • 20 Days 2352.90
    • 200 Days 2208.60
    2454.87 PIVOT
    First Support 2428.73 First Resistance 2502.13 Second Support 2381.47 Second Resistance 2528.27 Third Support 2355.33 Third Resistance 2575.53
    RSI 71.73 ADX 28.88 MACD 38.24 Williams % R -2.20 Commodity Channel Index (CCI) 149.97
    Date 2026-07-03 Week 629641.00 Same Day 478557.00 Month 438918.00
    1 Year 0.57 3 Year 0.58
    Over 1 Month
    9.49% down
    Over 1 Year
    26.66% down
    Over 3 Months
    8.60% down
    Over 3 Years
    40.52% down
    Over 6 Months
    18.82% down
    Over 5 Years
    16.41% down

    LUPIN LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    25 Jul 2025 12.0 Final 25 Jul 2025 Equity shares
    16 Jul 2024 8.0 Final 16 Jul 2024 Equity shares
    14 Jul 2023 4.0 Final 14 Jul 2023 Equity shares
    14 Jul 2022 4.0 Final 15 Jul 2022 Equity shares
    27 Jul 2021 6.5 Final 28 Jul 2021 Equity shares
    03 Aug 2020 6.0 Final 05 Aug 2020 Equity shares
    29 Jul 2019 5.0 Final 31 Jul 2019 Equity shares
    30 Jul 2018 5.0 Final 01 Aug 2018 Equity shares
    24 Jul 2017 7.5 Final 26 Jul 2017 Equity shares
    25 Jul 2016 7.5 Final 27 Jul 2016 Equity shares
    14 Jul 2015 7.5 Final 16 Jul 2015 Equity shares
    21 Jul 2014 3.0 Final 23 Jul 2014 Equity shares
    13 Feb 2014 3.0 Interim 14 Feb 2014 Equity shares
    29 Jul 2013 4.0 Final 31 Jul 2013 Equity shares
    13 Jul 2012 3.2 Final 17 Jul 2012 Equity shares
    18 Jul 2011 3.0 Final 20 Jul 2011 Equity shares
    19 Jul 2010 13.5 Final 21 Jul 2010 Equity shares
    20 Jul 2009 12.5 Final 22 Jul 2009 Equity shares
    11 Jul 2008 5.0 Special 15 Jul 2008 Equity shares
    11 Jul 2008 5.0 Final 15 Jul 2008 Equity shares
    10 Jul 2007 5.0 Final 12 Jul 2007 Equity shares
    15 Jul 2005 0.0 Final 19 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    14 Aug 2006 11 Aug 2006 1:1
    Ex-Date Old FV NEW FV Record Date
    27 Aug 2010 10.0 2.0 30 Aug 2010
    Dividend date Dividend amount Dividend type Record date Instrument type
    25 Jul 2025 12.0 Final 25 Jul 2025 Equity shares
    16 Jul 2024 8.0 Final 16 Jul 2024 Equity shares
    14 Jul 2023 4.0 Final 14 Jul 2023 Equity shares
    14 Jul 2022 4.0 Final 15 Jul 2022 Equity shares
    27 Jul 2021 6.5 Final 28 Jul 2021 Equity shares
    03 Aug 2020 6.0 Final 05 Aug 2020 Equity shares
    29 Jul 2019 5.0 Final 31 Jul 2019 Equity shares
    30 Jul 2018 5.0 Final 01 Aug 2018 Equity shares
    24 Jul 2017 7.5 Final 26 Jul 2017 Equity shares
    25 Jul 2016 7.5 Final 27 Jul 2016 Equity shares
    14 Jul 2015 7.5 Final 16 Jul 2015 Equity shares
    21 Jul 2014 3.0 Final 23 Jul 2014 Equity shares
    13 Feb 2014 3.0 Interim 14 Feb 2014 Equity shares
    29 Jul 2013 4.0 Final 31 Jul 2013 Equity shares
    13 Jul 2012 3.2 Final 17 Jul 2012 Equity shares
    18 Jul 2011 3.0 Final 20 Jul 2011 Equity shares
    19 Jul 2010 13.5 Final 21 Jul 2010 Equity shares
    20 Jul 2009 12.5 Final 22 Jul 2009 Equity shares
    11 Jul 2008 5.0 Special 15 Jul 2008 Equity shares
    11 Jul 2008 5.0 Final 15 Jul 2008 Equity shares
    10 Jul 2007 5.0 Final 12 Jul 2007 Equity shares
    15 Jul 2005 0.0 Final 19 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    14 Aug 2006 11 Aug 2006 1:1
    Ex-Date Old FV NEW FV Record Date
    27 Aug 2010 10.0 2.0 30 Aug 2010

    Top Gainers

    Top Losers

    About the Company

    Lupin Limited was founded in 1968 by Dr. Desh Bandhu Gupta, who had studied chemistry and taught at BITS Pilani before moving to Mumbai. His aim was to make quality medicines affordable for diseases of the highest national priority.. The company is headquartered in Mumbai, Maharashtra. Lupin Limited is listed on the National Stock Exchange under the ticker LUPIN and on BSE under the security code 500257.

    Lupin makes generic and complex generic drugs across therapeutic areas — cardiovascular, anti-infective, anti-tuberculosis, diabetology, paediatrics, and respiratory, among others. The company entered the United States in 2003 through Lupin Pharmaceuticals Inc., its US commercialisation arm. Lupin Limited has presence across more than 100 countries. 

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Lupin Ltd?

    Answer Field

    Lupin Ltd share price is for NSE ₹ 2,491.60 & for BSE ₹ 2,490.00 as on Jul 06 2026 03:30 PM.

    What is the Market Cap of Lupin Ltd Share?

    Answer Field

    The market cap of Lupin Ltd for NSE ₹ 0.01 & for BSE ₹ 0.01 as on Jul 06 2026 03:30 PM.

    What is the 52 Week High and Low of Lupin Ltd?

    Answer Field

    The 52 Week High and Low of Lupin Ltd for NSE is ₹ 2,504.60 and ₹ 1,836.80 and for BSE is ₹ 2,504.95 and ₹ 1,838.65.

    What is 1 year return for Lupin Ltd?

    Answer Field

    The 1 year returns on the stock has been 26.66%.

    What is the P/E Ratio of Lupin Ltd Share?

    Answer Field

    As on Jul 06 2026 03:30 PM the price-to-earnings (PE) ratio for Lupin Ltd share is 17.78.

    What is the PB ratio of Lupin Ltd Share?

    Answer Field

    As on Jul 06 2026 03:30 PM, the price-to-book (PB) ratio for Lupin Ltd share is 659.04.

    How to Buy Lupin Ltd Share?

    Answer Field

    You can trade in Lupin Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Lupin Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Lupin Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Lupin Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    Who is the CEO of Lupin Ltd?

    Answer Field

    As of now, the CEO of Lupin Ltd is Vinita Gupta, who has been leading the company through various strategic expansions and acquisitions.

    When was Lupin Ltd established?

    Answer Field

    Lupin Ltd was established in 1983 under the name Lupin Chemicals Ltd before it was later renamed Lupin Ltd in 2001.

    What factors influence the Lupin Share Price?

    Answer Field

    The Lupin share price is influenced by several factors including the company’s financial performance, market conditions, product approvals, regulatory news (particularly from the US FDA), acquisitions, partnerships and the performance of key therapeutic segments such as cardiovascular, anti-TB and generic drugs. Additionally, global market conditions and the company’s expansion into emerging markets also play a role.

    Is Lupin Ltd debt-free?

    Answer Field

    Lupin Ltd is not debt-free. However, like many large pharmaceutical companies, Lupin manages its debt levels based on capital requirements for expansion and R&D. The company's debt position can be subject to fluctuations depending on acquisitions and investments in new products or markets.

    What is the CAGR of Lupin Share?

    Answer Field

    The Compound Annual Growth Rate (CAGR) of Lupin's share price over various periods is 3% over 10 years, 22% over 5 years, 29% over 3 years and 69% over the past year, reflecting a strong recent performance in comparison to its longer-term growth trajectory.

    How has the Lupin Share Price performed over the past year?

    Answer Field

    Lupin’s share price has experienced fluctuations over the past year, influenced by various factors including product launches, regulatory approvals and acquisitions. Specific details about its performance can be found by analysing recent market data or consulting financial reports.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |